Stable formulations of anti-TIGIT antibodies alone and in combination with programmed death receptor 1 (PD-1) antibodies and methods of use thereof

• 收藏
• 分享

专利权人:

Merck Sharp & Dohme Corp.

发明人:

De, Arnab,Narasimhan, Chakravarthy Nachu

申请号：

AU2018261080

公开号：

AU2018261080A1

申请日:

2018.05.01

申请国别(地区):

AU

年份:

2019

代理人:

摘要：

The present invention relates to stable formulations of antibodies against T cell immunoreceptor with Ig and ITIM domains (TIGIT), optionally further containing an anti-human programmed death receptor 1 (PD-1) antibody or antigen binding fragment thereof. Also provided are methods of treating various cancers and chronic infections with the formulations of the invention.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/